Further evidence for the presence of cannabinoid CB1, receptors in mouse vas deferens

Roger Guy Pertwee, G JoeAdigwe, Gabrielle Margaret Hawksworth

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Our results provide further evidence for the hypothesis that the mouse vas deferens contains cannabinoid CB1 receptors. Thus we found that in the presence of forskolin, the cannabinoid receptor agonist, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol) produced a concentration related inhibition of cyclic AMP production by the vas deferens (EC(50) = 6.0 nM). At 100 nM, SR141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl- 1H-pyrazole-3-carboxamide hydrochloride) attenuated this effect of CP 55,940, producing a parallel rightward shift in its log concentration-response curve (K-d = 4.3 nM). We also found that cyclic AMP production was inhibited by(-)-11-hydroxy-1',1'-dimethylheptyl-Delta(8)-tetrahydrocannabinol but not by the (+) enantiomer.

Original languageEnglish
Pages (from-to)169-172
Number of pages4
JournalEuropean Journal of Pharmacology
Volume296
Issue number2
DOIs
Publication statusPublished - 25 Jan 1996

Keywords

  • cannabinoid receptor
  • cannabinoid receptor antagonist
  • SR141716A
  • vas deferens, mouse
  • cAMP
  • adenylate cyclase
  • ACCUMULATION
  • Cannabinoid receptor
  • Cannabinoid receptor antagonist;
  • Vas deferens mouse

Cite this

Further evidence for the presence of cannabinoid CB1, receptors in mouse vas deferens. / Pertwee, Roger Guy; JoeAdigwe, G ; Hawksworth, Gabrielle Margaret.

In: European Journal of Pharmacology, Vol. 296, No. 2, 25.01.1996, p. 169-172.

Research output: Contribution to journalArticle

Pertwee, Roger Guy ; JoeAdigwe, G ; Hawksworth, Gabrielle Margaret. / Further evidence for the presence of cannabinoid CB1, receptors in mouse vas deferens. In: European Journal of Pharmacology. 1996 ; Vol. 296, No. 2. pp. 169-172.
@article{ee2082844c3b415fbf62570ff52656e2,
title = "Further evidence for the presence of cannabinoid CB1, receptors in mouse vas deferens",
abstract = "Our results provide further evidence for the hypothesis that the mouse vas deferens contains cannabinoid CB1 receptors. Thus we found that in the presence of forskolin, the cannabinoid receptor agonist, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol) produced a concentration related inhibition of cyclic AMP production by the vas deferens (EC(50) = 6.0 nM). At 100 nM, SR141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl- 1H-pyrazole-3-carboxamide hydrochloride) attenuated this effect of CP 55,940, producing a parallel rightward shift in its log concentration-response curve (K-d = 4.3 nM). We also found that cyclic AMP production was inhibited by(-)-11-hydroxy-1',1'-dimethylheptyl-Delta(8)-tetrahydrocannabinol but not by the (+) enantiomer.",
keywords = "cannabinoid receptor, cannabinoid receptor antagonist, SR141716A, vas deferens, mouse, cAMP, adenylate cyclase, ACCUMULATION, Cannabinoid receptor, Cannabinoid receptor antagonist;, Vas deferens mouse",
author = "Pertwee, {Roger Guy} and G JoeAdigwe and Hawksworth, {Gabrielle Margaret}",
year = "1996",
month = "1",
day = "25",
doi = "10.1016/0014-2999(95)00790-3",
language = "English",
volume = "296",
pages = "169--172",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Further evidence for the presence of cannabinoid CB1, receptors in mouse vas deferens

AU - Pertwee, Roger Guy

AU - JoeAdigwe, G

AU - Hawksworth, Gabrielle Margaret

PY - 1996/1/25

Y1 - 1996/1/25

N2 - Our results provide further evidence for the hypothesis that the mouse vas deferens contains cannabinoid CB1 receptors. Thus we found that in the presence of forskolin, the cannabinoid receptor agonist, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol) produced a concentration related inhibition of cyclic AMP production by the vas deferens (EC(50) = 6.0 nM). At 100 nM, SR141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl- 1H-pyrazole-3-carboxamide hydrochloride) attenuated this effect of CP 55,940, producing a parallel rightward shift in its log concentration-response curve (K-d = 4.3 nM). We also found that cyclic AMP production was inhibited by(-)-11-hydroxy-1',1'-dimethylheptyl-Delta(8)-tetrahydrocannabinol but not by the (+) enantiomer.

AB - Our results provide further evidence for the hypothesis that the mouse vas deferens contains cannabinoid CB1 receptors. Thus we found that in the presence of forskolin, the cannabinoid receptor agonist, CP 55,940 ((-)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol) produced a concentration related inhibition of cyclic AMP production by the vas deferens (EC(50) = 6.0 nM). At 100 nM, SR141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl- 1H-pyrazole-3-carboxamide hydrochloride) attenuated this effect of CP 55,940, producing a parallel rightward shift in its log concentration-response curve (K-d = 4.3 nM). We also found that cyclic AMP production was inhibited by(-)-11-hydroxy-1',1'-dimethylheptyl-Delta(8)-tetrahydrocannabinol but not by the (+) enantiomer.

KW - cannabinoid receptor

KW - cannabinoid receptor antagonist

KW - SR141716A

KW - vas deferens, mouse

KW - cAMP

KW - adenylate cyclase

KW - ACCUMULATION

KW - Cannabinoid receptor

KW - Cannabinoid receptor antagonist;

KW - Vas deferens mouse

U2 - 10.1016/0014-2999(95)00790-3

DO - 10.1016/0014-2999(95)00790-3

M3 - Article

VL - 296

SP - 169

EP - 172

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -